CompletedNCT01301183
Hormone Treatment and Bone Development in Teenagers With Anorexia
About this title
Read the official source — NCT01301183Medication studyAges 14–22United StatesEating disorders
Understand this study
Who was this study for?
Listed age limits: 14 years to 22 years.
- Listed locations
- BostonSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: February 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 75
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 14 Years to 22 Years
- Official registry ID
- NCT01301183
- Official title
Show the full official title
Effects of Anorexia Nervosa on Peak Bone Mass
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Boston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including RhIGF-1 with transdermal 17-beta estradiol and Placebo and transdermal 17-beta estradiol.
Who was this study for?
Listed age limits: 14 years to 22 years.
